Publication Date:
2011-11-23
Description:
In the mid-1970s, breast cancer survival rates were dismal. Researchers hoped to find a drug capable of thwarting the disease, but the prospects were few and far between. In a laboratory on the campus of the Worcester Foundation for Experimental Biology in Shrewsbury, Massachusetts, a group of experimental rats were dying from breast cancer. A researcher gave them a triphenyl ethylene—a purported antiestrogen—with the slim hope that it would slow progression of the disease. The cancer disappeared (1). Within a few years, a clinical trial of the drug was launched among women suffering from breast cancer. The women's tumors, just...
Keywords:
PNAS Profiles
Print ISSN:
0027-8424
Electronic ISSN:
1091-6490
Topics:
Biology
,
Medicine
,
Natural Sciences in General